NCT01660802View on ClinicalTrials.gov

Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)

PHASE3CompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

September 4, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

May 20, 2014

Conditions
Macular Edema
Interventions
DRUG

700 μg Dexamethasone

700 μg Dexamethasone intravitreal injection in the study eye on Day 1.

OTHER

Sham

Sham administered in the study eye on Day 1.

Trial Locations (1)

Unknown

Beijing

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01660802 - Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO) | Biotech Hunter | Biotech Hunter